A clinical trial to study the effect of some herbal drugs in pain after vaginal delivery

A prospective study on the effect of Trikatvadi Churna in sutika makkal shool

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012542

Enrollment

Registered

2018-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ayurvedic formulation Trikatvadi Churna: Ayurvedic formulation Trikatvadi Churna 3 gram BD with luke warm water for 15 days Control Intervention1: Ayurvedic formulation Yavkshar: Ayurve

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in present study after giving the proper consent 2.Patient complaining of lower abdominal pain after vaginal delivery 3.Multi and primipara women

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years or more than 40 years 2.Cases delivered by caesarean section or any assisted technique 3.Grand multipara (parity >= 4) 4.Cases having history of any disease of central nervous system like epilepsy, meningitis, migraine etc. 5.Cases having history of any disease of respiratory system like bronchial asthma, tuberculosis, pneumonia, pleural effusion, bronchitis etc. 6.Cases having history of any cardiac disorder like hypertension, angina, myocardial infarction, congenital anomaly of heart etc. 7.Cases having history of any gastrointestinal disorder like appendicitis, cholecystitis, hepatitis, pancreatitis, cholelithiasis, diverticulitis, gastric ulcer, irritable bowel syndrome etc. 8.Cases suffering from any systemic disease like anaemia, malaria, typhoid, jaundice, diabetes mellitus, thyroid dysfunction, coagulation disorders etc. 9.Cases having history of hypersensitivity to any commonly used drugs. 10.Cases having history of blood transfusion. 11.Patients having history of any surgical condition like any benign or malignant growth in genital tract, genital prolapse etc. 12.Patients not given consent for participation in the study

Design outcomes

Primary

Measure	Time frame
Analysis of abdominal pain after vaginal delivery through numeric pain rating score and visual analogue scaleTimepoint: First follow-up at 10th day, second follow up at 15th day and last follow up at 30th day of delivery	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSabhyata Singh

Banaras Hindu University

drneelamaditi@rediffmail.com

Outcome results